LYMErix™
Company
GlaxoSmithKline
Use
A noninfectious recombinant vaccine for Lyme's disease
Features
The first vaccine for the prevention of Lyme's disease
NIH Contribution
Generated the expression vector pAS1 used for large scale recombinant protein production
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
M. Rosenberg
Year
1999
Tech Cat
Vaccine
